Ethical and scientific issues in studying the safety of approved drugs /

"An estimated 48 percent of the population takes at least one prescription drug in a given month. Drugs provide great benefits to society by saving or improving lives. Many drugs are also associated with side effects or adverse events, some serious and some discovered only after the drug is on...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2012.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Drugs > Testing > Moral and ethical aspects > United States.
Drug approval > United States.
Clinical trials > Moral and ethical aspects > United States.
Drug Evaluation > ethics
Clinical Trials as Topic > ethics
Drug Approval
Product Surveillance, Postmarketing > methods
Médicaments > Essais cliniques > Aspect moral > États-Unis.
Études cliniques > Aspect moral > États-Unis.
Médicaments > Autorisation de mise sur le marché > États-Unis.
BUSINESS & ECONOMICS > Business Ethics.
Clinical trials > Moral and ethical aspects
Drug approval
Drugs > Testing > Moral and ethical aspects
United States
dissertations.
Academic theses
Academic theses.
Thèses et écrits académiques.
Acceso en línea:Texto completo

Internet

Texto completo

Items no disponibles

Detalle de Existencias desde

Ejemplares similares